P1.01-84 Interaction of Lorlatinib with CYP2B6, CYP2C9, UGT, and P-gp Probe Drugs in Patients with Advanced Non-Small Cell Lung Cancer

Autor:	Alice T. Shaw, C. Tanski, Jill S. Clancy, Ben Solomon, E. Felip, H. Mamdani, Rita Chiari, Joseph Chen, M. O'Gorman, D. Kim, Yazdi K. Pithavala, Jessica Bauman, S-H.I. Ou, Ross A. Soo, Alessandra Bearz, K. Lee
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Oncology CYP2B6 business.industry medicine Cancer research In patient Non small cell Lung cancer medicine.disease business Lorlatinib CYP2C9
Zdroj:	Journal of Thoracic Oncology. 14:S392-S393
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2019.08.799
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f89bc6cb919d1e761a34b4f66bfa5f4b https://doi.org/10.1016/j.jtho.2019.08.799 Zobrazit plný text záznamu